Insights

Articles Jun252020

Sufficiency at the UK Supreme Court in Regeneron Pharmaceuticals Inc v Kymab Ltd

The UK Supreme Court handed down the judgment in a much anticipated biotech decision on 24 June. The Court found that Regeneron’s patents are invalid for lack of sufficient disclosure.

Articles Apr142020

Pressing pause on intellectual property: Part three – trade marks

This three-part series examines how intellectual property protection can continue in a productive and effective way, during this time of remote working, shifting priorities, uncertainty and change.

Articles Mar092020

The Trade Secrets Directive – Shh, Don’t Tell Anyone!

Bill Lister discusses 'trade secrets' and their benefits.

Articles Feb112020

EPO to take a second look at double patenting

The European Patent Convention does not explicitly prohibit double patenting. However, the European Patent Office has, for some time now, prohibited the granting of two patents to the same applicant for the same subject matter.

Articles Jan272018

Broad Institute CRISPR Patent Decision

The Board of Appeal of the EPO dismissed the Broad Institute’s appeal against the Opposition Division’s previous decision to revoke one of their patents covering CRISPR gene editing technology (EP2771468) on 16 January 2020.